{"id":"177lu-betabart","safety":{"commonSideEffects":[{"rate":"30%","effect":"Nausea"},{"rate":"20%","effect":"Vomiting"},{"rate":"40%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL3707297","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"177Lu-BetaBart is a radioligand therapy that selectively targets and binds to somatostatin receptors on neuroendocrine tumors, delivering cytotoxic radiation to the tumor cells.","oneSentence":"Targeting somatostatin receptors","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T06:50:18.401Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Neuroendocrine tumors"}]},"trialDetails":[{"nctId":"NCT07189871","phase":"PHASE1, PHASE2","title":"177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Radiopharm Theranostics, Ltd","startDate":"2026-02-23","conditions":"Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer, NSCLC (Non-small Cell Lung Cancer)","enrollment":61}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["RV-01","B335 177Lu-DOTA-anti-B7-H3"],"phase":"phase_1","status":"active","brandName":"177Lu-BetaBart","genericName":"177Lu-BetaBart","companyName":"Radiopharm Theranostics, Ltd","companyId":"radiopharm-theranostics-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Targeting somatostatin receptors Used for Neuroendocrine tumors.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}